Skip to main content

ORIGINAL RESEARCH article

Front. Microbiol.
Sec. Virology
Volume 15 - 2024 | doi: 10.3389/fmicb.2024.1456415

Characterization of the emerging recombinant infectious bronchitis virus in China

Provisionally accepted
Kaicheng Wang Kaicheng Wang 1*Suchun Wang Suchun Wang 1Junhui Pan Junhui Pan 1Kaiyutai Zhou Kaiyutai Zhou 1Dianfeng Chu Dianfeng Chu 2Jinji Li Jinji Li 2Yiping Chen Yiping Chen 1Qian Qi Qian Qi 1Shimeng Wei Shimeng Wei 1Chao Li Chao Li 1Jinyu Sui Jinyu Sui 1Faxing Wu Faxing Wu 1Jinping Li Jinping Li 1Guangyu Hou Guangyu Hou 1Hualei Liu Hualei Liu 1
  • 1 China Animal Health and Epidemiology Center, Qingdao, China
  • 2 Qingdao Yibang Biological Engineering Co., Ltd., Qingdao, Shandong Province, China

The final, formatted version of the article will be published soon.

    Infectious bronchitis virus (IBV) can cause serious harm to poultry industry. It is belong to Coronaviridae which is highly variable. A kind of emerging recombinant IBV (ahysx-1) has been detected in chicken from China in 2016. To understand the epidemiology and characterization of the emerging recombinant IBV, 35,455 samples of chickens from the 15 provinces in China were collected and detected. One hundred and ninety-six out of the 537 flocks (positive rate, 36.49%), and 908 out of 35,455 samples (positive rate, 2.56%) were positive in the detection.The results showed that the emerging recombinant IBV was pandemic in China.Thirteen emerging recombinant IBV isolates were selected and continuous subcultured to the fourth generation and analyzed by Next-generation sequencing.Compared with the reported sequence of ahysx-1, the genomic analysis showed that multiple position insertions and deletions were in 1a gene, 3b gene, M gene and N gene. The identity of the S gene nucleotide sequence between all the 13 emerging recombinant IBV isolates and reference stain ahysx-1 were 98.1% to 99.1%, while the identity of amino acid sequence were 98.0% to 99.8%. To better understand the recombination mechanism of the emerging recombinant IBV, the genomic sequence of the 13 isolates were compared with turkey coronavirus or guinea fowl coronavirus.The results suggest that all the 13 emerging recombinant IBV isolates were likely to be the recombination of turkey coronavirus or guinea fowl coronavirus with IBV.Turkey coronavirus or guinea fowl coronavirus as minor parents are the donors of S gene. The major parents donors of the genome backone of these recombination events were lineages GⅠ-19 or GⅥ-1 of IBV. One isolate (IBV/chicken/Henan/H1173/2021) was selected for pathogenicity analysis. The results showed that IBV/chicken/Henan/H1173/2021 was avirulent to SPF embryonated eggs, but could cause intestinal symptomsin of chicks. This study provides a foundation for understanding the epidemic situation and characterization of the emerging recombinant IBV. It is of great significance for the prevention and control of avian coronavirus infection.

    Keywords: emerging recombinant IBV, Epidemiology, characterization, recombination, pathogenicity

    Received: 28 Jun 2024; Accepted: 18 Sep 2024.

    Copyright: © 2024 Wang, Wang, Pan, Zhou, Chu, Li, Chen, Qi, Wei, Li, Sui, Wu, Li, Hou and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Kaicheng Wang, China Animal Health and Epidemiology Center, Qingdao, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.